Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC T...

por Yang, James Chih-Hsin, Mok, Tony S.K., Lu, Shun, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Shi, Yuan-Kai, Zhang, Li, Soo, Ross A., Morita, Satoshi, Tamura, Tomohide
Publicado 2021

Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers

por Li, Lili, Li, Chen, Mao, Haitao, Du, Zhenfang, Chan, Wai Yee, Murray, Paul, Luo, Bing, Chan, Anthony TC, Mok, Tony SK, Chan, Francis KL, Ambinder, Richard F, Tao, Qian
Publicado 2016

Corrigendum: Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers

por Li, Lili, Li, Chen, Mao, Haitao, Du, Zhenfang, Chan, Wai Yee, Murray, Paul, Luo, Bing, Chan, Anthony TC, Mok, Tony SK, Chan, Francis KL, Ambinder, Richard F, Tao, Qian
Publicado 2016

Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the pha...

por West, Howard Jack, McCleland, Mark, Cappuzzo, Federico, Reck, Martin, Mok, Tony SK, Jotte, Robert M, Nishio, Makoto, Kim, Eugene, Morris, Stefanie, Zou, Wei, Shames, David, Das Thakur, Meghna, Shankar, Geetha, Socinski, Mark A
Publicado 2022

Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042

por Mansfield, Aaron S., Herbst, Roy S., de Castro, Gilberto, Hui, Rina, Peled, Nir, Kim, Dong-Wan, Novello, Silvia, Satouchi, Miyako, Wu, Yi-Long, Garon, Edward B., Reck, Martin, Robinson, Andrew G., Samkari, Ayman, Piperdi, Bilal, Ebiana, Victoria, Lin, Jianxin, Mok, Tony S.K.
Publicado 2021

A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma

por Chan, Stephen L., Cheng, Paul N.M., Liu, Angela M., Chan, Landon L., Li, Leung, Chu, Cheuk M., Chong, Charing C.N., Lau, Yat M., Yeo, Winnie, Ng, Kelvin K.C., Yu, Simon C.H., Mok, Tony S.K., Chan, Anthony W.H.
Publicado 2021

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1...

por de Castro, Gilberto, Kudaba, Iveta, Wu, Yi-Long, Lopes, Gilberto, Kowalski, Dariusz M., Turna, Hande Z., Caglevic, Christian, Zhang, Li, Karaszewska, Boguslawa, Laktionov, Konstantin K., Srimuninnimit, Vichien, Bondarenko, Igor, Kubota, Kaoru, Mukherjee, Rinee, Lin, Jianxin, Souza, Fabricio, Mok, Tony S.K., Cho, Byoung Chul
Publicado 2023

Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin

por Sun, Kun, Jiang, Peiyong, Cheng, Suk Hang, Cheng, Timothy H.T., Wong, John, Wong, Vincent W.S., Ng, Simon S.M., Ma, Brigette B.Y., Leung, Tak Y., Chan, Stephen L., Mok, Tony S.K., Lai, Paul B.S., Chan, Henry L.Y., Sun, Hao, Chan, K.C. Allen, Chiu, Rossa W.K., Lo, Y.M. Dennis
Publicado 2019